Psoriatic Arthritis Treatment Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of thePsoriatic Arthritis Treatment Market?
The psoriatic arthritis treatment market is growing due to the rise in psoriasis and psoriatic arthritis cases. Psoriasis, associated with psoriatic arthritis (PsA), has a significant incidence among patients. For example, a National Library of Medicine report indicates that the likelihood of developing PsA increases significantly with time after a psoriasis diagnosis. This growing prevalence is fueling the demand for PsA treatments.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp
#How Will the CAGR of the Psoriatic Arthritis Treatment Market Influence Its Overall Growth by 2034?
The psoriatic arthritis treatment market size has grown strongly in recent years. It will grow from $10.93 billion in 2024 to $12 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth is due to increased diagnosis rates, rising prevalence of psoriatic arthritis, greater awareness of treatments, and the expanding range of approved therapies, supported by government and pharmaceutical company investments.
The psoriatic arthritis treatment market is set for strong growth, reaching $17.16 billion by 2029 at a CAGR of 9.4%. Growth is driven by personalized medicine, emerging biologics and small molecules, expanding treatment options, and a growing aging population. Major trends include advances in biologics, oral small molecules, targeted therapies, telemedicine and remote monitoring, patient-centered care, and real-world evidence.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3458
What Are the Most Significant Market Trends Transforming thePsoriatic Arthritis Treatment Market?
In the psoriatic arthritis treatment market, companies are focusing on advanced products like targeted biologic therapies to offer more personalized treatments. For example, AbbVie’s SKYRIZI (risankizumab-rzaa), approved in January 2022, is an interleukin-23 inhibitor designed to target inflammation at its source, showing significant improvements in joint symptoms and overall disease activity.
Who Are the Major Industry Players Accelerating Growth in thePsoriatic Arthritis Treatment Market?
Major companies operating in the psoriatic arthritis treatment market include AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., CB Biosciences Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Abbott Laboratories, Eisai Inc., Janssen Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline plc, LEO Pharma A/S, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.
Which Primary Segments of the Psoriatic Arthritis Treatment Market Are Driving Growth and Industry Transformations?
The psoriatic arthritis treatment market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors
2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics
4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3458&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of thePsoriatic Arthritis Treatment Market?# Market?
The countries covered in the psoriatic arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Browse Through More Reports Similar to the Global Psoriatic Arthritis Treatment Market 2025, By The Business Research Company:
Hydroxychloroquine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report
Arthritis Monoclonal Antibodies Global Market Report 2024
Musculoskeletal Disorders Drugs Global Market Report 2022
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
